Home
/
Westlake Chemical Partners LP
/
Financials
/
Quarterly
Westlake Chemical Partners LP — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Westlake Chemical Partners LP filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$308.90M
Oct 31, 2025
Q2
2025
Jun 30, 2025
$297.12M
Aug 6, 2025
Q1
2025
Mar 31, 2025
$237.63M
May 2, 2025
Q3
2025
Sep 30, 2024
$277.00M
Oct 31, 2025
Q2
2025
Jun 30, 2024
$284.17M
Aug 6, 2025
Q1
2025
Mar 31, 2024
$284.67M
May 2, 2025
Q3
2024
Sep 30, 2023
$321.66M
Nov 6, 2024
Q2
2024
Jun 30, 2023
$264.18M
Aug 9, 2024
Q1
2024
Mar 31, 2023
$307.68M
May 2, 2024
Q3
2023
Sep 30, 2022
$415.12M
Nov 2, 2023
Q2
2023
Jun 30, 2022
$448.79M
Aug 3, 2023
Q1
2023
Mar 31, 2022
$362.40M
May 4, 2023
Q3
2022
Sep 30, 2021
$293.97M
Nov 3, 2022
Q2
2022
Jun 30, 2021
$322.23M
Aug 3, 2022
Q1
2022
Mar 31, 2021
$268.21M
May 4, 2022
Q3
2021
Sep 30, 2020
$231.97M
Nov 3, 2021
Q2
2021
Jun 30, 2020
$238.50M
Aug 4, 2021
Q1
2021
Mar 31, 2020
$250.55M
May 5, 2021
Q3
2020
Sep 30, 2019
$249.93M
Nov 4, 2020
Q2
2020
Jun 30, 2019
$270.06M
Aug 6, 2020
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2023
Mar 31, 2023
$50.21M
May 4, 2023
Q3
2022
Sep 30, 2022
$50.85M
Nov 3, 2022
Q2
2022
Jun 30, 2022
$83.67M
Aug 3, 2022
Q1
2023
Mar 31, 2022
$71.74M
May 4, 2023
Q3
2022
Sep 30, 2021
$46.08M
Nov 3, 2022
Q2
2022
Jun 30, 2021
$81.27M
Aug 3, 2022
Q1
2022
Mar 31, 2021
$48.40M
May 4, 2022
Q3
2021
Sep 30, 2020
$14.21M
Nov 3, 2021
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2018
Jun 30, 2018
$301.98M
Aug 2, 2018
Q1
2018
Mar 31, 2018
$284.27M
May 3, 2018
Q3
2017
Sep 30, 2017
$296.78M
Nov 7, 2017
Q2
2018
Jun 30, 2017
$290.11M
Aug 2, 2018
Q1
2018
Mar 31, 2017
$277.45M
May 3, 2018
Q3
2017
Sep 30, 2016
$229.35M
Nov 7, 2017
Q2
2017
Jun 30, 2016
$210.84M
Aug 3, 2017
Q1
2017
Mar 31, 2016
$252.60M
May 3, 2017
Q3
2016
Sep 30, 2015
$248.62M
Nov 9, 2016
Q2
2016
Jun 30, 2015
$251.71M
Aug 9, 2016
Q1
2016
Mar 31, 2015
$258.39M
May 4, 2016
Q3
2015
Sep 30, 2014
$392.01M
Nov 4, 2015
Q2
2014
Jun 30, 2014
$524.14M
Sep 8, 2014
Q2
2014
Jun 30, 2013
$524.76M
Sep 8, 2014
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$14.65M
Oct 31, 2025
Q2
2025
Jun 30, 2025
$14.56M
Aug 6, 2025
Q1
2025
Mar 31, 2025
$4.95M
May 2, 2025
Q3
2025
Sep 30, 2024
$18.14M
Oct 31, 2025
Q2
2025
Jun 30, 2024
$14.43M
Aug 6, 2025
Q1
2025
Mar 31, 2024
$14.83M
May 2, 2025
Q3
2024
Sep 30, 2023
$13.21M
Nov 6, 2024
Q2
2024
Jun 30, 2023
$11.89M
Aug 9, 2024
Q1
2024
Mar 31, 2023
$14.89M
May 2, 2024
Q3
2023
Sep 30, 2022
$14.76M
Nov 2, 2023
Q2
2023
Jun 30, 2022
$16.44M
Aug 3, 2023
Q1
2023
Mar 31, 2022
$16.19M
May 4, 2023
Q3
2022
Sep 30, 2021
$12.79M
Nov 3, 2022
Q2
2022
Jun 30, 2021
$25.10M
Aug 3, 2022
Q1
2022
Mar 31, 2021
$15.15M
May 4, 2022
Q3
2021
Sep 30, 2020
$18.54M
Nov 3, 2021
Q2
2021
Jun 30, 2020
$14.86M
Aug 4, 2021
Q1
2021
Mar 31, 2020
$17.75M
May 5, 2021
Q3
2020
Sep 30, 2019
$14.92M
Nov 4, 2020
Q2
2020
Jun 30, 2019
$13.73M
Aug 6, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$91.98M
Oct 31, 2025
Q2
2025
Jun 30, 2025
$91.23M
Aug 6, 2025
Q1
2025
Mar 31, 2025
$46.61M
May 2, 2025
Q3
2025
Sep 30, 2024
$109.69M
Oct 31, 2025
Q2
2025
Jun 30, 2024
$93.63M
Aug 6, 2025
Q1
2025
Mar 31, 2024
$95.10M
May 2, 2025
Q3
2024
Sep 30, 2023
$86.24M
Nov 6, 2024
Q2
2024
Jun 30, 2023
$80.49M
Aug 9, 2024
Q1
2024
Mar 31, 2023
$98.16M
May 2, 2024
Q3
2023
Sep 30, 2022
$81.82M
Nov 2, 2023
Q2
2023
Jun 30, 2022
$87.38M
Aug 3, 2023
Q1
2023
Mar 31, 2022
$83.21M
May 4, 2023
Q3
2022
Sep 30, 2021
$68.14M
Nov 3, 2022
Q2
2022
Jun 30, 2021
$122.76M
Aug 3, 2022
Q1
2022
Mar 31, 2021
$79.03M
May 4, 2022
Q3
2021
Sep 30, 2020
$94.14M
Nov 3, 2021
Q2
2021
Jun 30, 2020
$83.89M
Aug 4, 2021
Q1
2021
Mar 31, 2020
$97.35M
May 5, 2021
Q3
2020
Sep 30, 2019
$86.40M
Nov 4, 2020
Q2
2020
Jun 30, 2019
$84.32M
Aug 6, 2020